Khvostova et al. investigated the polymorphism of estrogen-metabolizing enzymes (cytochromeP450s: CYP1A1, CYP1A2, and CYP19) in breast cancer patients within a cohort of Siberian women. This evidence concerns the gene CYP1A1 and breast cancer.